Compounds > gyki 53655
Page last updated: 2024-09-03

gyki 53655 and ly 300164

gyki 53655 has been researched along with ly 300164 in 4 studies

Compound Research Comparison

Studies
(gyki 53655)		Trials
(gyki 53655)		Recent Studies (post-2010)
(gyki 53655)		Studies
(ly 300164)		Trials
(ly 300164)		Recent Studies (post-2010) (ly 300164)
11102273712

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (50.00)18.2507
2000's2 (50.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Ballyk, BA; Bath, CP; Bleakman, D; Bufton, HR; Kamboj, RK; Lodge, D; Palmer, AJ; Schoepp, DD; Sharpe, EF; Tarnawa, I; Woolley, ML1
Cotton, JL; Partin, KM1
Gacsályi, I; Gigler, G; Gyertyán, I; Lévay, G; Szabados, T2

Other Studies

4 other study(ies) available for gyki 53655 and ly 300164

ArticleYear
Activity of 2,3-benzodiazepines at native rat and recombinant human glutamate receptors in vitro: stereospecificity and selectivity profiles.
    Neuropharmacology, 1996, Volume: 35, Issue:12

    Topics: alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid; Animals; Anti-Anxiety Agents; Benzodiazepines; Benzothiadiazines; Cell Line; Cerebellum; Cerebral Cortex; Excitatory Amino Acid Antagonists; Ganglia, Spinal; Humans; Kidney; Membrane Potentials; Molecular Structure; Neurons; Purkinje Cells; Rats; Rats, Sprague-Dawley; Receptors, AMPA; Recombinant Proteins; Spinal Cord; Structure-Activity Relationship; Transfection

1996
The contributions of GluR2 to allosteric modulation of AMPA receptors.
    Neuropharmacology, 2000, Volume: 39, Issue:1

    Topics: Allosteric Regulation; Amino Acid Substitution; Animals; Benzodiazepines; Benzothiadiazines; Cell Membrane; Excitatory Amino Acid Antagonists; Membrane Potentials; Oocytes; Receptors, AMPA; Recombinant Proteins; Xenopus laevis

2000
Duration of action of GYKI 52466 and its analogues in antiepileptic, anti-ischaemic and muscle relaxant tests.
    Neurobiology (Budapest, Hungary), 1999, Volume: 7, Issue:1

    Topics: Animals; Anti-Anxiety Agents; Benzodiazepines; Brain Ischemia; Epilepsy; Excitatory Amino Acid Antagonists; Mice; Muscle Relaxants, Central

1999
Comparison of anticonvulsive and acute neuroprotective activity of three 2,3-benzodiazepine compounds, GYKI 52466, GYKI 53405, and GYKI 53655.
    Brain research bulletin, 2001, Volume: 55, Issue:3

    Topics: Acoustic Stimulation; Animals; Anti-Anxiety Agents; Anticonvulsants; Benzodiazepines; Brain Ischemia; Dose-Response Relationship, Drug; Electroshock; Magnesium Chloride; Male; Mice; Mice, Inbred Strains; Neuroprotective Agents; Seizures; Survival Analysis; Time Factors

2001